Brito-García A, Gutiérrez-García F, Trujillo-Álvarez Y, Peña-Fresneda N, Barberia-Torres D, Díaz-Báez N

Language: Spanish
References: 11
Page: 275-281
PDF size: 252.98 Kb.

ABSTRACT

Performing renal transplantation in sensitized patients is a challenge for transplant programs. In October 2009, an observational, analytical, cross study was performed in patients from Havana on the transplant waiting list, to determine the mortality rate due to lymphocyte anti-HLA antibodies or PRA (panel reactivity antibody) and to identify related factors. Microlymphocytotoxicity technique was used and when PRA % 20 patients were considered not sensitize; sensitized when PRA % 20, and hypersensitive, when PRA % 75. To compare groups of sensitized and non-sensitized patients we used the homogeneity test (qualitative variables) and Student's t test (quantitative variables). Sixty eight not sensitized patients and 60 were sensitized; 43,3% of sensitized patients were candidates for retransplantation, higher value than the one observed in non-sensitized patients (8.8 %) (p = 0.00). In the sensitized group the frequency of transfused patients was 100 % and 86.8 % (p = 0.00) in the non-sensitized ones The average time on the waiting list was 112 months for sensitized patients, significantly higher than the 36 months for the non-sensitized group (p = 0.00). Possible factors related to patient sensitization were transfusion administration, time in the transplant waiting list and number of transplants received.

REFERENCES

1. Braun WE. Laboratory and clinical management of the highly sensitize organ transplant recipient. Hum Immunol. 1989 Dic;26(4):245-60.

2. Arce S. Avances en el trasplante renal de órganos y tejidos. La Habana: Editorial Ciencias Médicas; 1980.

3. Terasaki PI, Kreisler M, Mickey RM. Presensitization and kidney transplant failures. Post-Grad Med.1971 Feb;47(544):89-100.

4. Turka LA, Goguen IE, Gagne JE, Milford EL. Presensitization and the renal allograft recipient. Transplantation. 1989 Feb;47(2):234-40.

5. Opelz G, Wujciak B. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Inmunogenetics. 1999;1(3):334-42.

6. Scornic JC. Alloinmuniation, memory and the interpretation off cross match results for renal transplantation. Transplantation. 1992;54(3):389-94.

7. Arce S. Trasplante renal y enfermedad renal crónica. Sistema de leyes integradoras. La Habana: Editorial Ciencias Médicas; 2009.

8. Terasaki PI, Mc Clelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964; 204 Dec:998-1000.

9. Gorodezky C, Vázquez A, Rangel R, Arroyo M, Galindo I. Manual de procedimientos serológicos y celulares de histocompatibilidad. México DF: INDRE; 2003. p. 1-174.

10. Arce S, Comptis O, Ramos F, Trujillo Y, Suárez O, Acosta A. Respondedores y no respondedores: su influencia en el trasplante renal de cadáver. Estudio preliminar. Rev Cub Invest Bioméd. 1988;7(2):132-40.

11. Sürsal C. Advances in pre and postrasplant inmunologic testing in kidney transplantation. J Trans Proceed. 2003;11(2):1234-7.